Robert A. Gabbay
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes Management and Education
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Family Practice top 2%
Papers in
-
- Diabetes Management and Research 40
- Diabetes Management and Education 32
- Diabetes Treatment and Management 17
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 13
-
- Primary Care and Health Outcomes 29
- Mobile Health and mHealth Applications 7
- Co-authors
- Billy S. Collins (12 shared papers)Vanita R. Aroda (12 shared papers)Nuha A. ElSayed (14 shared papers)Raveendhara R. Bannuru (16 shared papers)Kamlesh Khunti (13 shared papers)Chantal Mathieu (3 shared papers)John B. Buse (3 shared papers)Stefano Del Prato (3 shared papers)
- Journals
- Diabetes Care (20 papers)Diabetes Technology & Therapeutics (9 papers)Journal of Diabetes Science and Technology (8 papers)Diabetes Research and Clinical Practice (5 papers)The Journal of Clinical Endocrinology & Metabolism (4 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Robert A. Gabbay
137 papers receiving 7.9k citations
Robert A. Gabbay's Hit Papers
Peers
Comparison fields: 5 of 155
- Endocrinology, Diabetes and Metabolism 4.0k
- Family Practice 87
- Geriatrics and Gerontology 106
- General Health Professions 649
- Obstetrics and Gynecology 181
Countries citing papers authored by Robert A. Gabbay
This map shows the geographic impact of Robert A. Gabbay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Gabbay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Gabbay more than expected).
Fields of papers citing papers by Robert A. Gabbay
This network shows the impact of papers produced by Robert A. Gabbay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Gabbay. The network helps show where Robert A. Gabbay may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert A. Gabbay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2022 | 1044 |
| 2 | 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023 Hit paper breakdown → | 2022 | 588 |
| 3 | Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2022 | 571 |
| 4 | 6. Glycemic Targets: Standards of Care in Diabetes—2023 Hit paper breakdown → | 2022 | 438 |
| 5 | 2005 | 432 | |
| 6 | Economic Costs of Diabetes in the U.S. in 2022 Hit paper breakdown → | 2023 | 362 |
| 7 | 7. Diabetes Technology: Standards of Care in Diabetes—2023 Hit paper breakdown → | 2022 | 209 |
| 8 | 2000 | 202 | |
| 9 | 15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023 Hit paper breakdown → | 2022 | 194 |
| 10 | COVID-19, Hyperglycemia, and New-Onset Diabetes Hit paper breakdown → | 2021 | 189 |
| 11 | 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023 Hit paper breakdown → | 2022 | 189 |
| 12 | 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—2023 Hit paper breakdown → | 2022 | 152 |
| 13 | 2006 | 142 | |
| 14 | 13. Older Adults: Standards of Care in Diabetes—2023 Hit paper breakdown → | 2022 | 130 |
| 15 | 2022 | 121 | |
| 16 | 1996 | 119 | |
| 17 | 2011 | 117 | |
| 18 | 2022 | 116 | |
| 19 | 2022 | 96 | |
| 20 | 2005 | 84 |
About Robert A. Gabbay
Robert A. Gabbay is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions, Epidemiology, Molecular Biology and Genetics, having authored 140 papers that have together received 8.2k indexed citations. Recurring topics across this work include Diabetes Management and Research (40 papers), Diabetes Management and Education (32 papers), Primary Care and Health Outcomes (29 papers), Diabetes Treatment and Management (17 papers), Chronic Disease Management Strategies (16 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (13 papers), Diabetes and associated disorders (12 papers) and Mobile Health and mHealth Applications (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.0k citations), Family Practice (87 citations), Geriatrics and Gerontology (106 citations), General Health Professions (649 citations) and Obstetrics and Gynecology (181 citations). Robert A. Gabbay has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Billy S. Collins, Vanita R. Aroda, Nuha A. ElSayed, Raveendhara R. Bannuru, Kamlesh Khunti, Chantal Mathieu, John B. Buse, Stefano Del Prato, Geltrude Mingrone and Απόστολος Τσάπας. Their work appears in journals such as Diabetes Care, Diabetes Technology & Therapeutics, Journal of Diabetes Science and Technology, Diabetes Research and Clinical Practice and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.